Sign in
4

Changes in Ownership

Spyre Therapeutics, Inc. Filed Acc 0000950170-24-061085

Options or other derivatives

  • Director acquired 11,323 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Stelzer Laurie · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-05-14 Grant or award : show line 1 in the form Stock Option (Right to Buy) +11,323 11,323 D
Loading xslF345X05/ownership.xml…